Your browser doesn't support javascript.
loading
Long-term efficacy update of crizotinib in patients with advanced, inoperable inflammatory myofibroblastic tumour from EORTC trial 90101 CREATE.
Schöffski, Patrick; Kubickova, Michaela; Wozniak, Agnieszka; Blay, Jean-Yves; Strauss, Sandra J; Stacchiotti, Silvia; Switaj, Tomasz; Bücklein, Veit; Leahy, Michael G; Italiano, Antoine; Isambert, Nicolas; Debiec-Rychter, Maria; Sciot, Raf; Lee, Che-Jui; Speetjens, Frank M; Nzokirantevye, Axelle; Neven, Anouk; Kasper, Bernd.
Afiliação
  • Schöffski P; Department of General Medical Oncology, University Hospitals Leuven, Leuven Cancer Institute, Department of Oncology, KU Leuven, Laboratory of Experimental Oncology, Leuven, Belgium; Laboratory of Experimental Oncology, Department of Oncology, KU Leuven, Leuven, Belgium. Electronic address: patrick.
  • Kubickova M; National Cancer Institute, Bratislava, Slovakia.
  • Wozniak A; Laboratory of Experimental Oncology, Department of Oncology, KU Leuven, Leuven, Belgium.
  • Blay JY; Department of Medical Oncology, Centre Léon Bérard/Université Claude Bernard Lyon Institute, Lyon, France.
  • Strauss SJ; Department of Oncology, University College London Hospitals NHS Trust, London, UK.
  • Stacchiotti S; Department of Medical Oncology, IRCCS Fondazione Istituto Nazionale Tumori, Milano, Italy.
  • Switaj T; Department of Soft Tissue/Bone Sarcoma and Melanoma, Maria Sklodowska-Curie Institute-Oncology Center, Warsaw, Poland.
  • Bücklein V; Klinikum der Universität München, Medizinische Klinik III, Campus Grosshadern, Munich, Germany.
  • Leahy MG; The Christie NHS Foundation Trust, Manchester, UK.
  • Italiano A; Sarcoma Unit, Institut Bergonié, Bordeaux, France.
  • Isambert N; Department of Medical Oncology, Centre Georges François Leclerc, Dijon, France.
  • Debiec-Rychter M; Department of Human Genetics, KU Leuven, Leuven, Belgium.
  • Sciot R; Department of Pathology, University Hospitals Leuven, KU Leuven, Leuven, Belgium.
  • Lee CJ; Department of General Medical Oncology, University Hospitals Leuven, Leuven Cancer Institute, Department of Oncology, KU Leuven, Laboratory of Experimental Oncology, Leuven, Belgium.
  • Speetjens FM; Department of Medical Oncology, Leiden University Medical Center, Leiden, Netherlands.
  • Nzokirantevye A; European Organisation for Research and Treatment of Cancer, Brussels, Belgium.
  • Neven A; European Organisation for Research and Treatment of Cancer, Brussels, Belgium.
  • Kasper B; Sarcoma Unit, Mannheim University Medical Center, University of Heidelberg, Mannheim, Germany.
Eur J Cancer ; 156: 12-23, 2021 10.
Article em En | MEDLINE | ID: mdl-34392187
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Inibidores de Proteínas Quinases / Crizotinibe / Quinase do Linfoma Anaplásico / Neoplasias de Tecido Muscular / Antineoplásicos Tipo de estudo: Clinical_trials Limite: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged País/Região como assunto: Europa Idioma: En Revista: Eur J Cancer Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Inibidores de Proteínas Quinases / Crizotinibe / Quinase do Linfoma Anaplásico / Neoplasias de Tecido Muscular / Antineoplásicos Tipo de estudo: Clinical_trials Limite: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged País/Região como assunto: Europa Idioma: En Revista: Eur J Cancer Ano de publicação: 2021 Tipo de documento: Article